Details of the Drug Reposition

General Information of This Drug (ID: DMJ3KPO)

Drug Name
TD-101   DMJ3KPO
Drug Type
siRNA drug

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
1 Phase 2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Flavivirus infection DISK96WQ 1C80 Phase 2 [1]
------------------------------------------------------------------------------------
1 Phase 1 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Pachyonychia DISGQGGX EE10.3 Phase 1 [2]
------------------------------------------------------------------------------------

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
2 ClinicalTrials.gov (NCT00716014) Study of TD101, a Small Interfering RNA (siRNA) Designed for Treatment of Pachyonychia Congenita. U.S. National Institutes of Health.